Furthermore, a four-gene panel comprising CNN2, HMG20B, ACRBP, and IZUMO1 successfully distinguished DLBCL from follicular lymphoma (FL), achieving an AUC of 0.89 in the testing set, regardless of the cell-of-origin or stage of DLBCL [103]. This evidence concerns the gene CNN2 and follicular lymphoma.